UT-MD Anderson Cancer Center: AACR - Mutations in Three Key Genes Associated With Poor Outcomes in Lung Cancer Patients Treated With KRAS G12C Inhibitors
April 18, 2023
April 18, 2023
HOUSTON, Texas, April 18 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 17, 2023:
* * *
Study provides framework for personalizing treatment approaches and developing combination strategies for KRAS G12C-mutant lung cancer
* * *
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes - KE . . .
* * *
Study provides framework for personalizing treatment approaches and developing combination strategies for KRAS G12C-mutant lung cancer
* * *
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes - KE . . .